应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02410 同源康医药-B
已收盘 03-16 16:08:22
10.840
+0.040
+0.37%
最高
10.930
最低
10.620
成交量
143.10万
今开
10.800
昨收
10.800
日振幅
2.87%
总市值
41.20亿
流通市值
40.70亿
总股本
3.80亿
成交额
1,541万
换手率
0.38%
流通股本
3.75亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
同源康医药-B03月11日主力净流出24.9万元 散户资金买入
市场透视 · 03-11
同源康医药-B03月11日主力净流出24.9万元 散户资金买入
每日卖空追踪 | 同源康医药-B 03月09日卖空量成交1.4万股,卖空比例为0.63%
市场透视 · 03-09
每日卖空追踪 | 同源康医药-B 03月09日卖空量成交1.4万股,卖空比例为0.63%
同源康医药-B03月06日获主力加仓207.5万元
市场透视 · 03-06
同源康医药-B03月06日获主力加仓207.5万元
港股异动 | 同源康医药-B(02410)涨超5% 公司完成H股全流通 艾多替尼上市申请获正式受理并纳入优先审评
智通财经网 · 03-06
港股异动 | 同源康医药-B(02410)涨超5% 公司完成H股全流通 艾多替尼上市申请获正式受理并纳入优先审评
同源康医药-B(02410)更新翌日披露报表,持股变动1.23%
公告速递 · 03-04
同源康医药-B(02410)更新翌日披露报表,持股变动1.23%
同源康医药-B(02410)2026年2月无新增发行或股份变动
公告速递 · 03-04
同源康医药-B(02410)2026年2月无新增发行或股份变动
同源康医药-B(02410):完成H股全流通
智通财经 · 03-04
同源康医药-B(02410):完成H股全流通
每日卖空追踪 | 同源康医药-B 03月04日卖空量成交1.8万股,卖空比例为0.29%
市场透视 · 03-04
每日卖空追踪 | 同源康医药-B 03月04日卖空量成交1.8万股,卖空比例为0.29%
同源康医药-B03月03日主力净流出150.0万元 散户资金买入
市场透视 · 03-03
同源康医药-B03月03日主力净流出150.0万元 散户资金买入
同源康医药-B创历史新低
格隆汇 · 03-03
同源康医药-B创历史新低
同源康医药-B(02410):同源康生物将获增资8350万元
智通财经 · 02-27
同源康医药-B(02410):同源康生物将获增资8350万元
同源康医药与多方达成协议 向泰科生物增资649万元
美股速递 · 02-27
同源康医药与多方达成协议 向泰科生物增资649万元
每日卖空追踪 | 同源康医药-B 02月25日卖空量成交2.45万股,卖空比例为2.34%
市场透视 · 02-25
每日卖空追踪 | 同源康医药-B 02月25日卖空量成交2.45万股,卖空比例为2.34%
每日卖空追踪 | 同源康医药-B 02月16日卖空量成交1500股,卖空比例为1.74%
市场透视 · 02-16
每日卖空追踪 | 同源康医药-B 02月16日卖空量成交1500股,卖空比例为1.74%
每日卖空追踪 | 同源康医药-B 02月13日卖空量成交1.3万股,卖空比例为1.15%
市场透视 · 02-13
每日卖空追踪 | 同源康医药-B 02月13日卖空量成交1.3万股,卖空比例为1.15%
同源康医药-B02月13日主力净流入76.5万元 散户资金抛售
市场透视 · 02-13
同源康医药-B02月13日主力净流入76.5万元 散户资金抛售
同源康医药-B(02410):联交所就实施H股全流通授出上市批准
智通财经 · 02-12
同源康医药-B(02410):联交所就实施H股全流通授出上市批准
每日卖空追踪 | 同源康医药-B 02月11日卖空量成交7000股,卖空比例为0.42%
市场透视 · 02-11
每日卖空追踪 | 同源康医药-B 02月11日卖空量成交7000股,卖空比例为0.42%
同源康医药-B02月10日遭主力抛售93.1万元
市场透视 · 02-10
同源康医药-B02月10日遭主力抛售93.1万元
同源康医药-B(02410):甲磺酸艾多替尼片(TY-9591片)的新药上市申请获国家药品监督管理局受理
智通财经 · 02-06
同源康医药-B(02410):甲磺酸艾多替尼片(TY-9591片)的新药上市申请获国家药品监督管理局受理
加载更多
公司概况
公司名称:
同源康医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发,其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI,对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。
发行价格:
--
{"stockData":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药-B","latestPrice":10.84,"timestamp":1773648502005,"preClose":10.8,"halted":0,"volume":1431000,"delay":0,"changeRate":0.0037037037037036245,"floatShares":375457818,"shares":380065818,"eps":-1.146139,"marketStatus":"已收盘","change":0.04,"latestTime":"03-16 16:08:22","open":10.8,"high":10.93,"low":10.62,"amount":15408812,"amplitude":0.028704,"askPrice":10.89,"askSize":11500,"bidPrice":10.83,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.845803,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773711000000},"marketStatusCode":5,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":10.8,"openAndCloseTimeList":[[1773624600000,1773633600000],[1773637200000,1773648000000]],"volumeRatio":0.82283,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02410","defaultTab":"news","newsList":[{"id":"2618925456","title":"同源康医药-B03月11日主力净流出24.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618925456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618925456?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:16","pubTimestamp":1773216967,"startTime":"0","endTime":"0","summary":"03月11日, 同源康医药-B股价跌0.63%,报收11.03元,成交金额1268.9万元,换手率0.30%,振幅2.34%,量比0.32。同源康医药-B今日主力资金净流出24.9万元,上一交易日主力净流入45.9万元。该股近5个交易日上涨6.46%,主力资金累计净流入272.4万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出111.2万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162237a460ad55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162237a460ad55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","BK1574","02410"],"gpt_icon":0},{"id":"2618646404","title":"每日卖空追踪 | 同源康医药-B 03月09日卖空量成交1.4万股,卖空比例为0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618646404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618646404?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间03月09日,涨0.81%,卖空量成交1.4万股,较上一交易日增加12%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163410a45ae812&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163410a45ae812&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09939","BK1515","02410"],"gpt_icon":0},{"id":"2617652988","title":"同源康医药-B03月06日获主力加仓207.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617652988","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617652988?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:15","pubTimestamp":1772784925,"startTime":"0","endTime":"0","summary":"03月06日, 同源康医药-B股价涨3.06%,报收11.10元,成交金额4762.6万元,换手率1.12%,振幅7.24%,量比1.19。同源康医药-B今日主力资金净流入207.5万元,上一交易日主力净流入43.9万元。该股近5个交易日下跌12.22%,主力资金累计净流出69.3万元;近20日主力资金累计净流出111.0万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161641a6aa2a7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161641a6aa2a7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2617250977","title":"港股异动 | 同源康医药-B(02410)涨超5% 公司完成H股全流通 艾多替尼上市申请获正式受理并纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2617250977","media":"智通财经网","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617250977?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:55","pubTimestamp":1772769322,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,同源康医药-B涨超5%,截至发稿,涨4.92%,报11.34港元,成交额2758.77万港元。消息面上,3月4日,同源康医药-B发布公告,本公司董事会欣然宣布,460.8万股非上市股份已于2026年3月4日完成转换为H股,该等经转换H股将于2026年3月5日上午九时正开始于联交所上市。近期,同源康医药-B宣布,其自主研发的针对非小细胞肺癌脑转移的甲磺酸艾多替尼片新药上市申请已获得中国国家药品监督管理局药品审评中心正式受理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["VXUS","BK1574","02410","09939","BK1515","VT","159938","BK4588","BK4585","BK1161"],"gpt_icon":0},{"id":"1115404116","title":"同源康医药-B(02410)更新翌日披露报表,持股变动1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115404116","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115404116?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:01","pubTimestamp":1772614913,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司(同源康医药-B,02410)于2026年3月4日发布公告,披露公司已发行股本变动情况。公告显示,公司将4,608,000股非上市股份转换为同等数量的H股,占转换前公司已发行H股总数的约1.23%。\n本次股份转换完成后,公司H股由375,457,818股增至380,065,818股,非上市股份则由4,608,000股降至0股。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。\n公告由执行董事、董事长兼总裁吴豫生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"1142666953","title":"同源康医药-B(02410)2026年2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1142666953","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142666953?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:53","pubTimestamp":1772614417,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司(同源康医药-B,02410)于2026年3月4日发布2026年2月股份变动月报表,报告期截至2026年2月28日。\n公司公告显示,截至本月底,H股发行数量维持375,457,818股,与上月底持平;非上市股份数量则维持4,608,000股,总股本维持380,065,818股。报告期内,公司并无新增发行、购回、注销或库藏股变动。\n公告同时披露,公司已符合相关公众持股量要求。期内并无股份期权或可换股票据等其他股本相关变动或交易安排。公司确认遵守香港联交所上市规则及相关法律规定。\n本次公告由执行董事、董事长兼总裁吴豫生签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"2616538316","title":"同源康医药-B(02410):完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538316","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538316?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:41","pubTimestamp":1772613660,"startTime":"0","endTime":"0","summary":"智通财经APP讯,同源康医药-B(02410)发布公告,本公司董事会欣然宣布,460.8万股非上市股份已于2026年3月4日完成转换为H股,该等经转换H股将于2026年3月5日上午九时正开始于联交所上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1515","02410","BK1574","09939","159938"],"gpt_icon":0},{"id":"2617500345","title":"每日卖空追踪 | 同源康医药-B 03月04日卖空量成交1.8万股,卖空比例为0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617500345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617500345?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间03月04日,跌3.98%,卖空量成交1.8万股,较上一交易日增加5.88%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163431a6a14fc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163431a6a14fc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","02410"],"gpt_icon":0},{"id":"2616375352","title":"同源康医药-B03月03日主力净流出150.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2616375352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616375352?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:15","pubTimestamp":1772525755,"startTime":"0","endTime":"0","summary":"03月03日, 同源康医药-B股价跌12.20%,报收10.80元,成交金额5925.7万元,换手率1.38%,振幅13.50%,量比4.55。同源康医药-B今日主力资金净流出150.0万元,上一交易日主力净流入34.0万元。该股近5个交易日下跌15.09%,主力资金累计净流出209.7万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出398.5万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162035a69c9b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162035a69c9b13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","02410"],"gpt_icon":0},{"id":"2616375349","title":"同源康医药-B创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2616375349","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616375349?lang=zh_cn&edition=full","pubTime":"2026-03-03 10:02","pubTimestamp":1772503335,"startTime":"0","endTime":"0","summary":"格隆汇3月3日丨同源康医药-B(02410.HK)跌1.79%,报12.0800港元,股价创历史新低,总市值45.91亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303104523a444753a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303104523a444753a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1161","BK1515","02410"],"gpt_icon":0},{"id":"2614585894","title":"同源康医药-B(02410):同源康生物将获增资8350万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614585894","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614585894?lang=zh_cn&edition=full","pubTime":"2026-02-27 20:06","pubTimestamp":1772194014,"startTime":"0","endTime":"0","summary":"增资完成后,同源康生物的总注册资本将由人民币1400万元增加至约人民币2049万元,而公司于同源康生物的权益将由约57.14%减少至39.03%,且同源康生物将不再为集团的附属公司。因此,该等交易将使集团能够将其资源集中于集团营运的其他方面,使集团能够更好地管理其营运,同时保留于同源康生物的重大权益及参与程度。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","159938","BK1515","BK1161","02410","BK1574"],"gpt_icon":0},{"id":"1141594891","title":"同源康医药与多方达成协议 向泰科生物增资649万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141594891","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141594891?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:57","pubTimestamp":1772193435,"startTime":"0","endTime":"0","summary":"同源康医药股份有限公司近日宣布,已与相关投资方共同签署协议,决定对旗下泰科生物(Tyk Bio)进行增资扩股。根据协议条款,本次增资总额为人民币649万元,将全部用于增加泰科生物的注册资本。\n此次增资完成后,泰科生物的资本实力将得到进一步增强,有助于加速其在生物医药领域的研发进程和业务拓展。市场分析认为,这一举措体现了股东对泰科生物发展前景的信心,也将为同源康医药在创新药领域的布局提供更有力的支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2614906193","title":"每日卖空追踪 | 同源康医药-B 02月25日卖空量成交2.45万股,卖空比例为2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614906193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614906193?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008234,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月25日,跌1.34%,卖空量成交2.45万股,较上一交易日增加512.5%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163421a4c6754d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163421a4c6754d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1574","09939","BK1161"],"gpt_icon":0},{"id":"2612243314","title":"每日卖空追踪 | 同源康医药-B 02月16日卖空量成交1500股,卖空比例为1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612243314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612243314?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230627,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月16日,跌0.31%,卖空量成交1500股,较上一交易日减少94.12%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1161","02410","BK1574"],"gpt_icon":0},{"id":"2611815925","title":"每日卖空追踪 | 同源康医药-B 02月13日卖空量成交1.3万股,卖空比例为1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611815925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611815925?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971432,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月13日,涨1.03%,卖空量成交1.3万股,较上一交易日增加333.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163438a49ff9e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163438a49ff9e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1515","BK1161","02410"],"gpt_icon":0},{"id":"2611137547","title":"同源康医药-B02月13日主力净流入76.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2611137547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611137547?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:15","pubTimestamp":1770970526,"startTime":"0","endTime":"0","summary":"02月13日, 同源康医药-B股价涨1.03%,报收12.80元,成交金额1435.5万元,换手率0.30%,振幅2.37%,量比0.48。同源康医药-B今日主力资金净流入76.5万元,上一交易日主力净流出86.9万元。该股近5个交易日下跌0.47%,主力资金累计净流出288.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出827.2万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161647a49fe5ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161647a49fe5ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1574","09939","02410"],"gpt_icon":0},{"id":"2610945167","title":"同源康医药-B(02410):联交所就实施H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2610945167","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610945167?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:07","pubTimestamp":1770887224,"startTime":"0","endTime":"0","summary":"智通财经APP讯,同源康医药-B(02410)公布,公司已向联交所上市委员会申请批准公司根据转换公司1名股东持有的460.8万股非上市股份转换的460.8万股H股上市及买卖经转换H股。联交所已于2026年2月11日授出上市批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159938","BK1515","09939","BK1574","02410"],"gpt_icon":0},{"id":"2610961373","title":"每日卖空追踪 | 同源康医药-B 02月11日卖空量成交7000股,卖空比例为0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610961373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610961373?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798633,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月11日,跌1.41%,卖空量成交7000股,较上一交易日减少81.08%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","02410","09939","BK1161"],"gpt_icon":0},{"id":"2610605754","title":"同源康医药-B02月10日遭主力抛售93.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610605754?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:16","pubTimestamp":1770711368,"startTime":"0","endTime":"0","summary":"02月10日, 同源康医药-B股价跌0.78%,报收12.76元,成交金额2489.9万元,换手率0.51%,振幅3.89%,量比0.87。同源康医药-B今日主力资金净流出93.1万元,上一交易日主力净流出134.1万元。该股近5个交易日上涨3.24%,主力资金累计净流出3.5万元;近20日主力资金累计净流出211.7万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1515","09939","BK1574"],"gpt_icon":0},{"id":"2609856571","title":"同源康医药-B(02410):甲磺酸艾多替尼片(TY-9591片)的新药上市申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2609856571","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609856571?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:02","pubTimestamp":1770368535,"startTime":"0","endTime":"0","summary":"智通财经APP讯,同源康医药-B 发布公告,本公司在研1类新药甲磺酸艾多替尼片的新药上市申请被国家药品监督管理局药品审评中心受理。甲磺酸艾多替尼片作为奥希替尼的氘代化合物,无论是从化学结构、药理作用、临床有效性和安全性、以及耐药机制分析,甲磺酸艾多替尼片都显示出更明显的临床价值和优势,对疾病的预后有明显改善作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402563.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","09939","BK1161","BK1515","TY","02410"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.1415},{"period":"3month","weight":-0.1775},{"period":"6month","weight":-0.2623},{"period":"1year","weight":-0.6143},{"period":"ytd","weight":-0.1762}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.066},{"period":"3month","weight":-0.0197},{"period":"6month","weight":-0.035},{"period":"1year","weight":0.0854},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发,其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI,对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","exchange":"SEHK","name":"同源康医药-B","nameEN":"TYK MEDICINES-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同源康医药-B,02410,同源康医药-B股票,同源康医药-B股票老虎,同源康医药-B股票老虎国际,同源康医药-B行情,同源康医药-B股票行情,同源康医药-B股价,同源康医药-B股市,同源康医药-B股票价格,同源康医药-B股票交易,同源康医药-B股票购买,同源康医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}